Courses

Accredited
Up to 1.5 CNE Contact Hours
The Rheumatology Nurses Society and Haymarket Medical Education present: Immunotherapy-Induced Rheumatic Diseases: Managing the Intersection of Rheumatology and Oncology Instructions To obtain credit, a...
Accredited
3.20 CNE / 3.20 Pharm
In this issue of Rheumatology Nurse Practice, we’ll follow a hypothetical patient from the moment they leave the rheumatology office with a DMARD prescription,...
Accredited
.50 CNE
Upon completion of this activity, participants should be able to: (1) Describe the immune response and cytokine mediators that trigger the development of SLE...
Accredited
.50 CNE
Upon completion of this activity, participants should be able to: (1) Assess recent evidence regarding the benefits and limitations of mainstay treatments used to...
Accredited
0.25 CNE / 0.25 Pharma
Upon completion of this activity, participants should be able to: (1) Apply lessons from case studies of patients with psoriatic arthritis (PsA) into the...
Accredited
0.25 CNE / 0.25 Pharma
Upon completion of this activity, participants should be able to: (1) Discuss the importance of managing issues such as comorbidities, side effects, and drug...
Accredited
0.25 CNE / 0.25 Pharma
Upon completion of this activity, participants should be able to: (1) Apply lessons from case studies of patients with psoriatic arthritis (PsA) into the...
Accredited
0.25 CNE / 0.25 Pharma
Upon completion of this activity, participants should be able to: (1) Discuss the importance of managing issues such as comorbidities, side effects, and drug...
Accredited
0.25 CNE / 0.25 Pharma
Upon completion of this activity, participants should be able to: (1) Apply lessons from case studies of patients with rheumatoid arthritis (RA) into the...
Accredited
0.25 CNE / 0.25 Pharma
Upon completion of this activity, participants should be able to: (1) Apply lessons from case studies of patients with psoriatic arthritis (PsA) into the...
Accredited
0.25 CNE / 0.25 Pharma
Upon completion of this activity, participants should be able to: (1) Apply lessons from case studies of patients with rheumatoid arthritis (RA) into the...
Accredited
0.25 CNE / 0.25 Pharma
Upon completion of this activity, participants should be able to: (1) Apply lessons from case studies of patients with psoriatic arthritis (PsA) into the...
Accredited
Educational Partnership
The goal of this activity is to increase awareness in targeted treatments for rheumatoid arthritis (RA) and psoriatic arthritis (PsA), as well as the...
Accredited
0.25 CNE / 0.25 Pharma
Upon completion of this activity, participants should be able to: (1) Apply lessons from case studies of patients with rheumatoid arthritis (RA) into the...
Accredited
3.10 CNE / 2.50 Pharm
In this issue we will explore the pathways that new agents under investigation for the treatment of psoriatic arthritis (PsA) are targeting. We will...
Accredited
5.0 CNE / 3.0 CNE Pharm
The 2018 Conference Enduring Course consists of a series of videos from passionate experts that presented at the 2018 11th Annual RNS Conference in...
Accredited
3.2 CNE / 2.8 Pharm
We will look at the association between obesity and rheumatoid arthritis and how the presence of excess weight impacts patient experience and response to...
Accredited
0.25 CNE / 0.25 Pharma
Upon completion of this activity, participants should be able to: (1) Apply lessons from case studies of patients with rheumatoid arthritis (RA) into the...
Accredited
3.0 CNE / 1.0 Pharma
This course will help you to dig deeper into your knowledge on immunology and biologics, preparing you for the day-to-day challenges in your practice.
Accredited
4.75 CNE / 2.0 Pharm
This course will allow you to gain greater knowledge and skill about Spondyloarthropathies (SpA), Reactive Arthritis (ReA), Inflammatory Bowel Disease (IBD), and more, to...
Accredited
3.2 CNE / 3.2 Pharm
We will take a look at current and anticipated guideline recommendations for treatment of PsA, the efficacy and safety of biologic and other agents,...
Accredited
3.2 CNE / 3.2 Pharm
We will explore the current body of evidence addressing the use of DMARD monotherapy, specifically biologic and targeted synthetic small molecule therapies, in patients...
Accredited
3.1 CNE / 2.4 Pharm
We will examine the pathophysiology of psoriatic arthritis, focusing on epidemiology, pathogenesis, and common presenting features of the disease. We’ll also review data reflecting...
Accredited
3.4 CNE / 1.0 Pharm
We will look at the key components of the first several visits to a rheumatology practice for an individual with suspected or newly diagnosed...
Accredited
1.75 CNE / 1.0 Pharma
We will provide an introductory level description of the basic immunology and pathophysiology of systemic lupus erythematosus (SLE) that will allow rheumatology nurses and...
Accredited
1.25 CNE / 0.8 Pharma
We will examine new insights into the pathophysiology of spondyloarthritis (SpA) that have led to changes in disease classification systems. This issue will also...